Your session is about to expire
← Back to Search
Peer Support for Diabetes (PLEASED Trial)
N/A
Waitlist Available
Led By Tricia Tang, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights
PLEASED Trial Summary
PLEASED is a 12-month program that aims to help South Asians with type 2 diabetes improve and sustain diabetes-related health outcomes e.g. glycemic control, quality of life...) achieved from previous short-term diabetes education program. Our goal is to provide a new generation of education and support that can be ongoing, patient-driven, and flexible to the dynamic and evolving conditions of patients' "real-word" environment and life circumstances.
Eligible Conditions
- Diabetes
PLEASED Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Glycemic Control measured by HbA1c
Secondary outcome measures
ApoB (g/L) will be collected using venous puncture blood draw
Blood pressure (mmHg) measured by Omron BP785 monitor
Body Mass Index (kg/m2)
+7 morePLEASED Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Peer SupportExperimental Treatment1 Intervention
Peer support intervention group: During the first 3 months of DSME, participants in the DSMS intervention group will be invited to attend 6 lifestyle change sessions delivered a 2-person peer leader team and conducted bi-weekly. Immediately following the 3 months of DSME, participants are invited to attend 9 months of weekly DSMS sessions (60-minutes per session) delivered by a Peer Leader. These sessions are designed to sustain the self-management gains achieved in the 3 months of DSME.
Group II: Wait-list ControlActive Control1 Intervention
Immediately following the 6 bi-weekly DSME sessions, participants randomized to the Wait-list control group will have completed their participation in the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peer Support
2011
N/A
~4780
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,936 Total Patients Enrolled
9 Trials studying Diabetes
283 Patients Enrolled for Diabetes
VGH and UBC Hospital FoundationOTHER
3 Previous Clinical Trials
219 Total Patients Enrolled
Tricia Tang, PhDPrincipal InvestigatorUniversity of British Columbia
1 Previous Clinical Trials
600 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger